Efficacy and safety of bexarotene combined with phototherapy in Japanese patients with Cutaneous T-cell Lymphomas
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 27 Oct 2017
At a glance
- Drugs Bexarotene (Primary)
- Indications Cutaneous T cell lymphoma
- Focus Therapeutic Use
- 27 Oct 2017 Last checked against University Hospital Medical Information Network - Japan record.
- 24 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 25 Oct 2016 New trial record